MedElevator Войти в исследования
← Поиск публикаций

DOI 10.3109/09273948.2015.1092558

Медицинская библиотека · Ocular immunology and inflammation · 2016

Safety and Efficacy of Gevokizumab in Patients with Behçet's Disease Uveitis: Results of an Exploratory Phase 2 Study.

Tugal-Tutkun Ilknur, Kadayifcilar Sibel, Khairallah Moncef, Lee Sung Chul, Ozdal Pinar, Özyazgan Yilmaz, Song Ji Hun, Yu Hyeong Gon, Lehner Valerie, de Cordoue Agnès, Bernard Oana, Gül Ahmet

Клиническое исследование II фазыСтатьяМногоцентровое исследованиеРандомизированное исследованиеПеревод пока не подготовлен

Аннотация

PURPOSE: To evaluate the safety and efficacy of gevokizumab for the treatment of Behçet's disease uveitis in a prospective, open-label, randomized phase 2 trial.

METHODS

Behçet's disease patients with new acute ocular exacerbation or at risk of exacerbation received 30 or 60 mg gevokizumab every 4 weeks intravenously or subcutaneously, on top of a stable regimen of immunosuppressives and corticosteroids (≤20 mg/day equivalent prednisolone). Patients withdrew in cases of ocular exacerbation.

RESULTS

A total of 21 patients were included (17 acute and 4 at-risk; mean duration of uveitis 45.6 ± 37.4 months). There were no serious adverse events related to gevokizumab. Recorded adverse events were mostly associated with exacerbation of uveitis or its complications. Response was evaluated for 14 acute patients and all showed rapid control of acute ocular exacerbation, mostly within 1 week, without any increase in corticosteroid dosage.

CONCLUSIONS

Gevokizumab was well tolerated and rapidly controlled acute ocular exacerbations of Behçet's disease uveitis without the need for high-dose corticosteroid.

Для цитирования: Tugal-Tutkun Ilknur, Kadayifcilar Sibel, Khairallah Moncef, Lee Sung Chul, Ozdal Pinar, Özyazgan Yilmaz, Song Ji Hun, Yu Hyeong Gon, Lehner Valerie, de Cordoue Agnès, Bernard Oana, Gül Ahmet. Safety and Efficacy of Gevokizumab in Patients with Behçet's Disease Uveitis: Results of an Exploratory Phase 2 Study.. Ocular immunology and inflammation. 2016. DOI: 10.3109/09273948.2015.1092558.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.